Banu Sis Selected Research

Banu Sis Research Topics

Disease

5	Neoplasms (Cancer) 03/2007 - 07/2002
4	Wounds and Injuries (Trauma) 11/2020 - 11/2006
2	Liver Diseases (Liver Disease) 04/2015 - 02/2010
2	Infections 04/2015 - 02/2008
2	Liver Failure 04/2015 - 02/2010
2	Nephrotic Syndrome (Syndrome, Nephrotic) 09/2011 - 01/2008
2	Renal Insufficiency (Renal Failure) 09/2011 - 06/2010
2	Psoriasis (Pustulosis Palmaris et Plantaris) 07/2006 - 07/2006
2	Neoplasm Metastasis (Metastasis) 01/2004 - 01/2004
1	Reperfusion Injury 11/2020
1	Burns 11/2020
1	Sepsis (Septicemia) 11/2020
1	Multiple Organ Failure (MODS) 11/2020
1	Arterial Occlusive Diseases (Arterial Occlusive Disease) 01/2020
1	Endarteritis 05/2015
1	Cholangitis 04/2015
1	Autoimmune Diseases (Autoimmune Disease) 04/2012
1	Atrophy 09/2011
1	Fibrosis (Cirrhosis) 09/2011
1	Proteinuria 06/2010
1	Breast Cyst 04/2009
1	Cysts 04/2009
1	Wound Infection (Wound Infections) 02/2008
1	Glomerulonephritis 01/2008
1	Hematuria 01/2008
1	Peritoneal Fibrosis 07/2007
1	Peritonitis 07/2007
1	Lymphatic Metastasis 03/2007
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 03/2007
1	Lung Injury 11/2006
1	Rheumatoid Arthritis 07/2006
1	Carcinogenesis 05/2005
1	Tetanus 06/2004
1	Diphtheria 06/2004
1	Paraganglioma (Paragangliomas) 03/2004
1	Carcinoma (Carcinomatosis) 01/2004
1	Colorectal Neoplasms (Colorectal Cancer) 01/2004

Drug/Important Bio-Agent (IBA)

2	AntibodiesIBA 04/2015 - 04/2012
2	Proteins (Proteins, Gene)FDA Link 03/2007 - 01/2004
2	TenascinIBA 01/2004 - 01/2004
2	Cathepsin DIBA 01/2004 - 01/2004
1	Oncostatin M Receptors (Oncostatin M Receptor)IBA 11/2020
1	Oncostatin MIBA 11/2020
1	Nitric Oxide Synthase Type III (Endothelial Nitric Oxide Synthase)IBA 01/2020
1	Apelin ReceptorsIBA 01/2020
1	CreatinineIBA 05/2015
1	lopinavir-ritonavir drug combination (Kaletra)FDA Link 04/2015
1	Reverse Transcriptase InhibitorsIBA 04/2015
1	EnzymesIBA 04/2015
1	Tenofovir (Viread)FDA Link 04/2015
1	Emtricitabine (Emtriva)FDA Link 04/2015
1	Protease Inhibitors (Protease Inhibitor)IBA 04/2015
1	Biomarkers (Surrogate Marker)IBA 04/2012
1	Tacrolimus (Prograf)FDA LinkGeneric 09/2011
1	SteroidsIBA 09/2011
1	A-factor (Streptomyces)IBA 09/2011
1	Urokinase-Type Plasminogen Activator (Urokinase)FDA Link 02/2010
1	Phosphorus (Red Phosphorus)IBA 04/2009
1	Trace Elements (Biometals)IBA 04/2009
1	ElectrolytesIBA 04/2009
1	Anti-Bacterial Agents (Antibiotics)IBA 02/2008
1	Ointments (Pastes)IBA 02/2008
1	Mupirocin (Bactroban)FDA LinkGeneric 02/2008
1	Petrolatum (Vaseline)FDA Link 02/2008
1	Nitrofurazone (Nitrofural)FDA Link 02/2008
1	Immunoglobulin M (IgM)IBA 01/2008
1	Angiotensin Receptor AntagonistsIBA 07/2007
1	Irbesartan FDA LinkGeneric 07/2007
1	Mineralocorticoid Receptor AntagonistsIBA 07/2007
1	Spironolactone (Aldactone)FDA LinkGeneric 07/2007
1	SurvivinIBA 03/2007
1	Glutamine (L-Glutamine)FDA Link 11/2006
1	Meloxicam (Mobic)FDA LinkGeneric 07/2006
1	Etanercept (Enbrel)FDA Link 07/2006
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 07/2006
1	anthraceneIBA 05/2005
1	Polycyclic Aromatic Hydrocarbons (Polynuclear Aromatic Hydrocarbons)IBA 05/2005
1	ErbB Receptors (EGF Receptor)IBA 11/2004
1	VaccinesIBA 06/2004
1	Chorionic Gonadotropin (Human Chorionic Gonadotropin)FDA LinkGeneric 03/2004
1	Matrix Metalloproteinase 2 (Gelatinase A)IBA 01/2004
1	ParaffinIBA 07/2002

Therapy/Procedure

4	Therapeutics 04/2015 - 11/2004
3	Transplantation 11/2020 - 02/2010
1	Peritoneal Dialysis 07/2007
1	Chemoprevention 05/2005